Keyphrases
Metformin
100%
Hepatocellular Carcinoma
100%
Chemopreventive
100%
Chemoprevention
28%
Malignancy
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Independent Risk Factors
14%
Survival Rate
14%
Mortality Rate
14%
Insulin Resistance
14%
Hepatitis C Virus
14%
Metabolic Syndrome
14%
Alcohol
14%
Antidiabetic Agents
14%
Virus Hepatitis
14%
Hepatitis B Virus
14%
Surveillance System
14%
Chronic Inflammation
14%
Delayed Diagnosis
14%
Non-alcoholic Fatty Liver Disease (NAFLD)
14%
Poor Survival
14%
Poor Prognosis
14%
Chronic Hepatitis
14%
Prognosis Survival
14%
Prevention Effect
14%
Independent Pathway
14%
Immunology and Microbiology
Survival Rate
100%
Hepatitis C Virus
100%
Hepatitis Virus
100%
Hepatitis B Virus
100%
Mortality Rate
100%
Insulin Resistance
100%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Metformin
100%
Ethanol
28%
Diabetes Mellitus
14%
Mortality Rate
14%
Survival Rate
14%
Antidiabetic Agent
14%
Hepatitis C Virus
14%
Insulin Resistance
14%
Metabolic Syndrome X
14%
Virus Hepatitis
14%
Hepatitis B Virus
14%
Chronic Inflammation
14%
Fatty Liver
14%
Chronic Hepatitis
14%